Infinitus joins hands with some of the world’s most prestigious universities in international sci-tech government project

Infinitus joins hands with some of the world's most prestigious universities in international sci-tech government project

The Chinese herbal health products maker teams up with South China University of Technology, Cambridge University and others institutions of higher learning in immune system enhancement and anti-aging study

GUANGZHOU, China, Oct. 29, 2022 /PRNewswire/ — In September of this year, the International Industrial Application Demonstration of Functional Foods for Delaying Aging and Enhancing Immunity project, led by South China University of Technology (SCUT) and jointly submitted by Infinitus (China) Co., Ltd., the University of Cambridge, Guangzhou Medical University and the University of the Western Cape of Africa under the umbrella of the Belt and Road initiative, was officially approved by the Guangdong Science and Technology Department. This was the first time that Infinitus has participated in and got approval for a collaborative international sci-tech project in the public sector.


A delegation from the Exchange and Cooperation Center of the Guangdong Science and Technology Department visits Infinitus Plaza

In response to and in support of China’s Belt and Road initiative, the project will undertake research in scientific formulation, efficient preparation, industrial application and clinical trial data collection and analysis of health care ingredients in the area of immune system enhancement and anti-aging. These endeavors are designed to form a closed-loop ecosystem throughout the industry supply chain, ranging from basic research and development (R&D), pilot tests, mass production, clinical human data feedback to product enhancement, providing a good example of product R&D, manufacturing, technology and promotion on a global scale. Serving as an integral part of the project, Infinitus will play a leading role in the demonstration and promotion of the industrial application, further enhancing the international presence of Infinitus and its products.

On October 14, a delegation from the Exchange and Cooperation Center of the Guangdong Science and Technology Department visited Infinitus Plaza to provide guidance on the project. Through field research, the delegates affirmed the company’s R&D strengths and ability to integrate scientific and technological resources, and expressed their expectation that Infinitus and other project participants can tap into their wells of creativity and facilitate the transformation of technological achievements, making a major contribution to the province’s ongoing global strategy by applying their industrial technologies in cooperating countries to create great economic benefits.

After years of basic research, the firm has made significant breakthroughs in core and key technologies in the fields of immune system enhancement and anti-aging. Under the guidance of the Guangdong Science and Technology Department, Infinitus will continue its strong commitment as a large company to leveraging its own R&D capabilities and working with a number of leading research institutions and colleges to apply these sci-tech innovations and achievements to the immune system enhancement and anti-aging segments, and to make a meaningful contribution to collaborative international sci-tech innovation projects.  

 

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PR Newswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, PR Newswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.